Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists

BACKGROUND: Observational data may inform novel drug development programs by identifying previously unappreciated, clinical benefits of existing drugs. Several preclinical and clinical studies have suggested emergent therapeutic utility of drugs acting on the N-methyl-d-aspartate (NMDA) receptor, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kern, David M., Cepeda, M. Soledad, Flores, Christopher M., Wittenberg, Gayle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907035/
https://www.ncbi.nlm.nih.gov/pubmed/33537916
http://dx.doi.org/10.1007/s40263-020-00789-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907035/
https://www.ncbi.nlm.nih.gov/pubmed/33537916
http://dx.doi.org/10.1007/s40263-020-00789-3

Ejemplares similares